Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Table 2 and Figure 2 show the levels of SAA and 25(OH)VD in subgroups of T2DM patients, which indicated that both SAA and 25(OH)D were significantly different in the subgroups of T2DM patients (p < 0.05).

Source: Levels of SAA and 25(OH)VD among T2DM patients grouped by UACR. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cross-sectional study.

Cross-sectional study

Examines a population at a particular point in time.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Associations of serum amyloid A and 25‐hydroxyvitamin D with diabetic nephropathy: A cross‐sectional study

Source: Article title.

A total of 240 patients with T2DM participated in this study, but only 182 patients were included in the end (58 patients were excluded based on the exclusion criteria).

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Associations of serum amyloid A and 25‐hydroxyvitamin D with diabetic nephropathy: A cross‐sectional study

Cross-sectional study · Journal of Clinical Laboratory Analysis · 2022

Original publication title

Associations of serum amyloid A and 25‐hydroxyvitamin D with diabetic nephropathy: A cross‐sectional study

Qian Liu; Jin Sun; Tongdao Xu; Guangrong Bian; Fumeng Yang

© 2022 The Authors. Journal of Clinical Laboratory Analysis published by Wiley Periodicals LLC.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

SAA and 25(OH)VD might be used as potential markers to identify patients at increased risk of developing DN.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

The present study investigated the relationships between serum amyloid A (SAA), 25‐hydroxyvitamin D (25(OH)VD) and diabetic nephropathy (DN) to provide evidence for the prevention and management of DN.

Source: Background

Abstract: What methods does the paper describe?

A total of 182 patients with type 2 diabetes mellitus (T2DM) were enrolled in this study. The levels of SAA, 25(OH)VD, and other conventional indicators were measured and analyzed. Receiver operating characteristic curve analysis was applied for the combined measurement of SAA and 25(OH)VD, and risk factors for DN were evaluated using binary logistic regression analysis.

Source: Methods

Abstract: Results

The levels of SAA in T2DM patients were significantly higher than those in healthy subjects, and the level significantly increased with the progression of DN (p < 0.05). In contrast, the level of 25(OH)VD in T2DM patients was significantly lower than that in healthy subjects, and the level significantly decreased with the progression of DN (p < 0.05). The combined measurement of SAA and 25(OH)VD distinguished DN patients from T2DM patients better than the measurement of SAA or 25(OH)VD alone.

SAA was an independent risk factor for DN, and 25(OH)VD was an independent protective factor for DN.

Source: Results

Abstract: Conclusion

SAA and 25(OH)VD might be used as potential markers to identify patients at increased risk of developing DN.

Source: Conclusion
Authors’ abstract

Abstract

Background

The present study investigated the relationships between serum amyloid A (SAA), 25‐hydroxyvitamin D (25(OH)VD) and diabetic nephropathy (DN) to provide evidence for the prevention and management of DN.

Methods

A total of 182 patients with type 2 diabetes mellitus (T2DM) were enrolled in this study. The levels of SAA, 25(OH)VD, and other conventional indicators were measured and analyzed. Receiver operating characteristic curve analysis was applied for the combined measurement of SAA and 25(OH)VD, and risk factors for DN were evaluated using binary logistic regression analysis.

Results

The levels of SAA in T2DM patients were significantly higher than those in healthy subjects, and the level significantly increased with the progression of DN (p < 0.05). In contrast, the level of 25(OH)VD in T2DM patients was significantly lower than that in healthy subjects, and the level significantly decreased with the progression of DN (p < 0.05). The combined measurement of SAA and 25(OH)VD distinguished DN patients from T2DM patients better than the measurement of SAA or 25(OH)VD alone.

SAA was an independent risk factor for DN, and 25(OH)VD was an independent protective factor for DN.

Conclusion

SAA and 25(OH)VD might be used as potential markers to identify patients at increased risk of developing DN.

Publication and source details

Original title: Associations of serum amyloid A and 25‐hydroxyvitamin D with diabetic nephropathy: A cross‐sectional study

Qian Liu; Jin Sun; Tongdao Xu; Guangrong Bian; Fumeng Yang

Journal of Clinical Laboratory Analysis · 2022

* Correspondence
Fumeng Yang, Department of Laboratory Medicine, The Second People's Hospital of Lianyungang, Lianyungang, PR China.
Email: yfm31095018@163.com
© 2022 The Authors. Journal of Clinical Laboratory Analysis published by Wiley Periodicals LLC.https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.Young and Middle‐aged Medical Talent Growth Fund of the Second People's Hospital of LianyungangTQ202101Key Project of the Natural Science Foundation of Bengbu Medical College 10.13039/5011000079242020byzd342

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T10:45:43.281790+00:00

DOI: 10.1002/jcla.24283 · PMC8906018